Diadenosine polyphosphates as antagonists of the endogenous P2Y1 receptor in rat brain capillary endothelial cells of the B7 and B10 clones

被引:21
作者
Vigne, P
Breittmayer, JP
Frelin, C
机构
[1] Univ Nice, Inst Pharmacol Mol & Cellulaire, CNRS, UPR 411, F-06560 Valbonne, France
[2] Hop Archet, INSERM, U343, F-06202 Nice 3, France
关键词
purinergic receptors; endothelial cells; calcium; cyclic AMP;
D O I
10.1038/sj.bjp.0703228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 Diadenosine polyphosphates (Ap(n)As, n = 2-7) are considered as stress mediators in the cardiovascular system. They act both via identified P2 purinoceptors and via yet to be characterized receptors. This study analyses the actions of Ap(n)As in clones of rat brain capillary endothelial cells that express P2Y(1) receptors (B10 cells) or both P2Y(1) and P2Y(2) receptors (B7 cells). 2 B10 cells responded to Ap(3)A with rises in intracellular Ca2+ concentration ([Ca2+](i)), This response was prevented by adenosine-3'-phosphate-5'-phosphate, an antagonist of P2Y(1) receptors. It was largely suppressed by a treatment with apyrase VII or with creatine phosphokinase/creatine phosphate to degrade contaminating ADP. 3 Ap(n)As inhibited ADP induced increases in [Ca2+](i) mediated by P2Y(1) receptors by shifting ADP concentration-response curves to larger concentrations. Apparent K-i values were estimated to be 6 mu M for Ap(4)A, 10 mu M for Ap(5)A and 47 mu M for Ap(6)A. Ap(2)A and Ap(3)A were much less active. 4 Ap(n)As were neither agonists nor antagonists of the endogenous P2Y(2) receptor in B7 cells. 5 Ap(n)As are neither agonists nor antagonists of the G(i)-coupled, ADP receptor in B10 cells. 6 The results suggest that most actions of Ap(n)As in B7 and B10 cells call be accounted for by endogenous P2Y(1) receptors. Ap(4)A, Ap(5)A and Ap(6)A are specific antagonists of endogenous Ca2+- coupled P2Y(1) receptors.
引用
收藏
页码:1506 / 1512
页数:7
相关论文
共 33 条
[1]   Regulation of cyclic AMP by extracellular ATP in cultured brain capillary endothelial cells [J].
Anwar, Z ;
Albert, JL ;
Gubby, SE ;
Boyle, JP ;
Roberts, JA ;
Webb, TE ;
Boarder, MR .
BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (02) :465-471
[2]  
Boyer JL, 1996, MOL PHARMACOL, V50, P1323
[3]  
BOZOU JC, 1986, MOL PHARMACOL, V29, P489
[4]   Characterization of signaling pathways of P-2Y and P-2U purinoceptors in bovine pulmonary artery endothelial cells [J].
Chen, BC ;
Lee, CM ;
Lee, YT ;
Lin, WW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (02) :192-199
[5]   Characterization of the P2 receptors on the human umbilical vein endothelial cell line ECV304 [J].
Conant, AR ;
Fisher, MJ ;
McLennan, AG ;
Simpson, AWM .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (02) :357-364
[6]   Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets [J].
Daniel, JL ;
Dangelmaier, C ;
Jin, JG ;
Ashby, B ;
Smith, JB ;
Kunapuli, SP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2024-2029
[7]   P2Y1-receptors in human platelets which are pharmacologically distinct from P2YADP-receptors [J].
Fagura, MS ;
Dainty, IA ;
McKay, GD ;
Kirk, IP ;
Humphries, RG ;
Robertson, MJ ;
Dougall, IG ;
Leff, P .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (01) :157-164
[8]   ATP, A PARTIAL AGONIST OF ATYPICAL P-2Y PURINOCEPTORS IN RAT-BRAIN MICROVASCULAR ENDOTHELIAL-CELLS [J].
FEOLDE, E ;
VIGNE, P ;
BREITTMAYER, JP ;
FRELIN, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (07) :1199-1203
[9]   The effects of diadenosine polyphosphates on the cardiovascular system [J].
Flores, NA ;
Stavrou, BM ;
Sheridan, DJ .
CARDIOVASCULAR RESEARCH, 1999, 42 (01) :15-26
[10]  
FRELIN C, 1993, J BIOL CHEM, V268, P8787